Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.62 USD | +3.33% |
|
+10.42% | -13.02% |
01:44pm | Truist Raises Price Target on Inari Medical to $60 From $47, Maintains Hold Rating | MT |
07-15 | Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.02% | 3.19B | |
+75.67% | 12.57B | |
-22.70% | 7.43B | |
-7.43% | 5.79B | |
+8.16% | 5.09B | |
-17.37% | 4.78B | |
+16.22% | 4.2B | |
-15.15% | 4.13B | |
-1.98% | 2B | |
+25.59% | 1.94B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Truist Raises Price Target on Inari Medical to $60 From $47, Maintains Hold Rating